Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mRNA-1345-P901 Study: RSV Outcomes Study Extension

NCT05572658 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05572658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05572658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mRNA-1345-P901 Study: RSV Outcomes Study Extension
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
September 15, 2022
Completion date
September 30, 2023
Enrollment
10,994 (actual)
Sites
109

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus